Combination of Anticholinergics and Inhibitors of Phosphodiesterase Type 4 For The Treatment of Respiratory Disease

The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R, R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory...

Full description

Saved in:
Bibliographic Details
Main Authors CNOTA PETER JUERGEN, SZELENYI ISTVAN, FYRNYS BEATRIX, MAUS JOACHIM
Format Patent
LanguageEnglish
Published 28.05.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R, R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer(R).
AbstractList The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R, R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer(R).
Author MAUS JOACHIM
SZELENYI ISTVAN
CNOTA PETER JUERGEN
FYRNYS BEATRIX
Author_xml – fullname: CNOTA PETER JUERGEN
– fullname: SZELENYI ISTVAN
– fullname: FYRNYS BEATRIX
– fullname: MAUS JOACHIM
BookMark eNqNy80KglAQhmEXtejvHgZaB5YStBRLahdlaznq1BnQGTlzNt59R-gCWn288HzLaMbCuIg0l74mNp6EQd6QsafGSkeM7kONguEWbmypJi9OJ3K3ooOVllA9OqMI5TggpFCIg9KGdGh8j-wn_UAdyJlwHuFMisGvo_nbdIqb366ibXEp8-sOB6kCNw0y-ur1PMTxaZ8c08Mp2yf_qS-eV0bY
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2009136429A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2009136429A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:00:53 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2009136429A13
Notes Application Number: US20090365003
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090528&DB=EPODOC&CC=US&NR=2009136429A1
ParticipantIDs epo_espacenet_US2009136429A1
PublicationCentury 2000
PublicationDate 20090528
PublicationDateYYYYMMDD 2009-05-28
PublicationDate_xml – month: 05
  year: 2009
  text: 20090528
  day: 28
PublicationDecade 2000
PublicationYear 2009
Score 2.7420092
Snippet The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Combination of Anticholinergics and Inhibitors of Phosphodiesterase Type 4 For The Treatment of Respiratory Disease
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090528&DB=EPODOC&locale=&CC=US&NR=2009136429A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTsXplIDSt2LXtF33UGTrhSm4jV1kb6NdUzqQdLQV_74n2er2tLfShJCGfDn5-p0LwItlxrbFQhuRRqlqsMRUQ43GKmUrKw67aPEi6eU7tAZz42NhLmrwXcXCyDyhvzI5IiJqhXgv5Xm92f_E8qRvZfEarfFV9hbMHE-p2HFXM3Vb8fqOPx55I1dxXWc-VYYT2dameNnu9pArnYiLtMi073_1RVzK5tCoBJdwOsbxeHkFNcYbcO5WtdcacPa5k7zxcYe-4hoKBC8SWTk9kiWkx0XUlKi6w3I8wAoS8pi883QdrUUNHdFlnGbFJs2Eq6AINS4YEcSTGCTIcoJbhMwqR3PRe7LX3Ym3VW5u4DnwZ-5Axdkv_xdrOZ8efiq9hTrPOLsDkoS0oyURE0ql0WGGTRnSmfYKjXgU64nZhNaxke6PNz_AxVZnMVXdbkG9zH_YI5rrMnqSq_wHvGiatQ
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT8IwFD4haMQ3RY0X1CaavS0C3Y0HYmBjAeUWGIY3srEukJiObDP-fU8LE554a9amaZt9Pf36ndMD8GrooWUw30KkUapqLNJVv0pDlbKlEfoNtHiB9PIdGt2Z9jHX5wX4zmNh5Duhv_JxRETUEvGeyf16s7_EcqRvZfoWrPFT_O56TUfJ2XGjqtctxWk3O-ORM7IV227OpspwIutqFA_bjRZypRMTSaEkS19tEZeyOTQq7gWcjrE_nl1CgfEylOw891oZzgY7yRuLO_SlV5AieJHIyuGROCItLqKmRNYdluAGlhKfh6THV-tgLXLoiCbjVZxuVrFwFRShxikjgngSjbhxQvAXIV7uaC5aT_a6O3G2ys01vLgdz-6qOPrF_2ItZtPDqdIbKPKYs1sgkU_NahQwoVRqJtMsypDO1JZoxIOwHul3UDnW0_3x6mcodb1Bf9HvDT8f4Hyruehq3apAMUt-2COa7ix4kiv-Bx3AnZ8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Combination+of+Anticholinergics+and+Inhibitors+of+Phosphodiesterase+Type+4+For+The+Treatment+of+Respiratory+Disease&rft.inventor=CNOTA+PETER+JUERGEN&rft.inventor=SZELENYI+ISTVAN&rft.inventor=FYRNYS+BEATRIX&rft.inventor=MAUS+JOACHIM&rft.date=2009-05-28&rft.externalDBID=A1&rft.externalDocID=US2009136429A1